SCHEMBL160723

SCHEMBL160723

ClCOc1cc2c(Br)cccc2cn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
NOS1 P29475 2/20 0.32
AXL P30530 1/20 0.32
GABRP O00591 3/20 0.31
GABRD O14764 3/20 0.31
GABRA1 P14867 3/20 0.31
GABRB1 P18505 3/20 0.31
GABRG2 P18507 3/20 0.31
GABRB3 P28472 3/20 0.31
GABRA5 P31644 3/20 0.31
GABRA3 P34903 3/20 0.31
GABRA2 P47869 3/20 0.31
GABRB2 P47870 3/20 0.31
GABRA4 P48169 3/20 0.31
GABRE P78334 3/20 0.31
GABRA6 Q16445 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31106358 0.80 GABRG2 (0.44) NPC1RAB9ANOS1GABRPGABRD
SCHEMBL23360135 0.80 GABRG2 (0.44) NPC1RAB9ANOS1GABRPGABRD
SCHEMBL161864 0.75 CYP1A2 (0.45) NPC1RAB9AKDM4EDRD3KCNH2
SCHEMBL12930800 0.74 GABRP (0.40) KMT2ANOS1AXLGABRPGABRD
SCHEMBL28666568 0.73 FGFR1 (0.39) KMT2ASMN1; SMN2LMNANOS1AXL
SCHEMBL30184761 0.73 FGFR1 (0.39) KMT2ASMN1; SMN2LMNANOS1AXL
SCHEMBL2747957 0.70 KDM4E (0.36) KMT2ASMN1; SMN2NOS1AXLBACE1
SCHEMBL31399686 0.70 CYP1A2 (0.53) SMN1; SMN2LMNANOS1AXLBACE1
SCHEMBL2171256 0.70 CYP1A2 (0.53) SMN1; SMN2LMNANOS1AXLBACE1
SCHEMBL31106357 0.70 KDM4E (0.36) KMT2ASMN1; SMN2NOS1AXLBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2663553-A2 QUINOLINE AND ISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-11-20 EP disclosed
WO-2012030944-A2 QUINOLINE AND ISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed
EP-2346830-A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck Sharp & Dohme Corp. (US) 2011-07-27 EP disclosed
WO-2010030722-A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK SHARP & DOHME CORP. (US) 2010-03-18 WO disclosed